RankingsPricing
  1. JP-listed companies
  2. TAKARA BIO INC.
  3. Financials
  4. Total assets

TAKARA BIO INC.JP:4974

Market cap
¥93.2B
P/E ratio
-10.4x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Mar 31, 2025125,334+3.37%
Mar 31, 2024121,252-6.15%
Mar 31, 2023129,202+11.66%
Mar 31, 2022115,712+28.93%
Mar 31, 202189,750+19.65%
Mar 31, 202075,009+5.59%
Mar 31, 201971,040+3.17%
Mar 31, 201868,854+2.55%
Mar 31, 201767,143+0.83%
Mar 31, 201666,591+0.25%
Mar 31, 201566,425

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)